Back

The prevalence and impact of changes in the severity of secondary TR during hospitalization in acute heart failure

1 September 2024 (12:00 - 12:15)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Session in Valvular Heart Disease Tricuspid Valve Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tetsuya Kobayashi

Juntendo University Graduate School of Medicine, Tokyo (Japan)

3 More presentations in this session

Presentation thumbnail
Residual tricuspid regurgitation after transcatheter tricuspid valve edge-to-edge repair: the EuroTR Registry
Mr L. Stolz (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Bacteremia after transcatheter aortic valve implantation: a nationwide cohort study.
Doctor K. Hadji-Turdeghal (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Multi-modal artificial intelligence-based prediction for cardiovascular mortality after transcatheter aortic valve implantation: a time-to-event survival prediction
Doctor I. Shiri (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Session in Valvular Heart Disease
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Secondary tricuspid regurgitation: from early identification to treatment
thumbnail
Congress Presentation
Prognostic value of hemodynamically significant secondary tricuspid regurgitation in patients hospitalised for heart failure with preserved ejection fraction.
thumbnail
Congress Presentation
Too little, too late: atrial secondary tricuspid regurgitation (A-STR) carries a better prognosis in early-stage heart failure, but not in late-stage

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources